Beijing, China · Founded 2019 · Privately Held (backing)
Provider of CDMO process development and GMP production services for cell culture, bioprocessing, and biologics-related technical applications. BioInno is based in Beijing, China and was founded in 2019. Its last reported valuation was $156 million in Dec 2021. It has raised $48.1 million.
Last reported valuation
$156.4M
Oct 2026
Priced at
—
Total raised
$48.1M
Last round
—
Cap table — not yet on record
BioInno's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioInno with a free account
·The complete investor list: 13 names
·Watch BioInno: the Monday email on marks, rounds and moves
